These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35976666)

  • 1. Nephrogenic Adenoma Intermixed With Urothelial Carcinoma.
    Kryvenko ON; Wasco MJ; Williamson SR
    Arch Pathol Lab Med; 2022 May; 147(5):552-558. PubMed ID: 35976666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibromyxoid Nephrogenic Adenoma: A Series of 43 Cases Reassessing Predisposing Conditions, Clinical Presentation, and Morphology.
    Li L; Williamson SR; Castillo RP; Delma KS; Gonzalgo ML; Epstein JI; Kryvenko ON
    Am J Surg Pathol; 2023 Jan; 47(1):37-46. PubMed ID: 36395466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases.
    Yang Z; Epstein JI
    Am J Surg Pathol; 2018 Jul; 42(7):971-976. PubMed ID: 29683821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.
    Seibel JL; Prasad S; Weiss RE; Bancila E; Epstein JI
    Hum Pathol; 2002 Feb; 33(2):236-41. PubMed ID: 11957151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
    Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
    Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
    Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
    BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial carcinoma with villoglandular differentiation: a study of 14 cases.
    Lim M; Adsay NV; Grignon D; Osunkoya AO
    Mod Pathol; 2009 Oct; 22(10):1280-6. PubMed ID: 19593329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma.
    Herawi M; Drew PA; Pan CC; Epstein JI
    Hum Pathol; 2010 Apr; 41(4):594-601. PubMed ID: 20060152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of atypical papillary urothelial hyperplasia.
    Swierczynski SL; Epstein JI
    Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.
    Lim MG; Adsay NV; Grignon DJ; Osunkoya AO
    Mod Pathol; 2011 Feb; 24(2):241-7. PubMed ID: 20818341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive papillary urothelial carcinoma with 'micropapillary' architecture: clinicopathological study of 18 patients emphasising clinical outcomes.
    Sangoi AR; Cox RM; Higgins JP; Quick CM; McKenney JK
    Histopathology; 2020 Nov; 77(5):728-733. PubMed ID: 32443178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephrogenic adenoma of the bladder. Morphological and immunophenotypic study with particular attention to differential diagnosis].
    Isimbaldi G; Di Nuovo F; Sironi M; Catania G; Bonacina R; Privitera O; Spinelli M
    Pathologica; 1999 Jun; 91(3):192-7. PubMed ID: 10536465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive urothelial carcinoma of the bladder with glandular differentiation: report of 24 cases.
    Miller JS; Epstein JI
    Am J Surg Pathol; 2009 Aug; 33(8):1241-8. PubMed ID: 19440144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
    Wasco MJ; Daignault S; Bradley D; Shah RB
    Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenic adenoma: an update on an innocuous but troublesome entity.
    Rahemtullah A; Oliva E
    Adv Anat Pathol; 2006 Sep; 13(5):247-55. PubMed ID: 16998318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.